Switching multiple sclerosis patients with breakthrough disease to second-line therapy.
Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, Cree BA, Goodin DS, Green AJ, Okuda DT, Pelletier D, Zamvil SS, Vittinghoff E, Waubant E.
Castillo-Trivino T, et al. Among authors: mowry em.
PLoS One. 2011 Feb 3;6(2):e16664. doi: 10.1371/journal.pone.0016664.
PLoS One. 2011.
PMID: 21304907
Free PMC article.